Clinical Professor of Internal Medicine
Service Chief
Hematology/Oncology
Associate Medical Director
Internal Medicine - Hematology/Oncology
1500 E. Medical Center Drive
Ann Arbor, MI 48109
[email protected]
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Available to mentor
Bryan Schneider
Clinical Professor
-
Center MemberRogel Cancer Center
-
Edwards DM, Schonewolf CA, Rice JD, Schipper M, Haken RKT, Matuszak M, Balter J, Jarema D, Arenberg DA, Piert M, Qin A, Kalemkerian GP, Schneider BJ, Ramnath N, Chapman CH, Elliott DA, Lawrence TS, Hearn J, Hayman JA, Jolly S. Int J Radiat Oncol Biol Phys, 2024 Dec 1; 120 (5): 1332 - 1343.Journal ArticlePhase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer.
DOI:10.1016/j.ijrobp.2024.06.018 PMID: 38971385 -
Shatila M, Zhang HC, Shirwaikar Thomas A, Machado AP, Naz S, Mittal N, Catinis C, Varatharajalu K, Colli Cruz C, Lu E, Wu D, Brahmer JR, Carbonnel F, Hanauer SB, Lashner B, Schneider B, Thompson JA, Obeid M, Farris DP, Wang Y. J Immunother Cancer, 2024 Nov 14; 12 (11):Journal ArticleSystematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
DOI:10.1136/jitc-2024-009742 PMID: 39542654 -
Thompson JA, Schneider BJ, Brahmer J, Zaid MA, Achufusi A, Armand P, Berkenstock MK, Bermas B, Braaten T, Budde LE, Chokshi S, Crees ZD, Davies M, Deng C, Gesthalter Y, Jain M, Jain P, Jallouk A, Kaffenberger BH, Khalil M, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Prosek J, Reddy S, Reid P, Ryan J, Ryder M, Salman H, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Zucker S, Lyons M, Awotiwon A, Hang L. J Natl Compr Canc Netw, 2024 Nov; 22 (9): 582 - 592.Journal ArticleNCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
DOI:10.6004/jnccn.2024.0057 PMID: 39536465 -
Owen DH, Jaiyesimi IA, Leighl NB, Ismaila N, Florez N, Puri S, Schenk EL, Schneider BJ, Patel JD. JCO Oncol Pract, 2024 Jul; 20 (7): 893 - 898.Journal ArticleTherapy for Stage IV Non-Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights.
DOI:10.1200/OP.24.00177 PMID: 38588478 -
Jaiyesimi IA, Leighl NB, Ismaila N, Alluri K, Florez N, Gadgeel S, Masters G, Schenk EL, Schneider BJ, Sequist L, Singh N, Bazhenova L, Blanchard E, Freeman-Daily J, Furuya N, Halmos B, Azar IH, Kuruvilla S, Mullane M, Naidoo J, Reuss JE, Spigel DR, Owen DH, Patel JD. J Clin Oncol, 2024 Apr 10; 42 (11): e23 - e43.Journal ArticleTherapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
DOI:10.1200/JCO.23.02746 PMID: 38417098 -
Jaiyesimi IA, Leighl NB, Ismaila N, Alluri K, Florez N, Gadgeel S, Masters G, Schenk EL, Schneider BJ, Sequist L, Singh N, Bazhenova L, Blanchard E, Freeman-Daily J, Furuya N, Halmos B, Azar IH, Kuruvilla S, Mullane M, Naidoo J, Reuss JE, Spigel DR, Owen DH, Patel JD. J Clin Oncol, 2024 Apr 10; 42 (11): e1 - e22.Journal ArticleTherapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
DOI:10.1200/JCO.23.02744 PMID: 38417091 -
Qin A, Wells L, Malhotra B, Gadgeel S, Schneider BJ, Ramnath N, Rice JD, Kalemkerian GP. Clin Lung Cancer, 2024 Mar; 25 (2): 128 - 134.Proceeding / Abstract / PosterA Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
DOI:10.1016/j.cllc.2023.10.011 PMID: 37977950 -
Sperling G, Shatila M, Varatharajalu K, Lu Y, Altan M, Zhou Y, Zhao D, De Toni EN, Török H-P, Schneider BJ, Khan A, Thomas AS, Zhang HC, Shafi MA, Wang Y. J Cancer Res Clin Oncol, 2023 Dec; 149 (19): 17597 - 17605.Journal ArticlePneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.
DOI:10.1007/s00432-023-05461-z PMID: 37917197
